The viral core proteins (pl5, p26, pll, and p9) of equine infectious anemia virus (EIAV) (Wyoming strain) were purifed by reverse-phase high-pressure liquid chromatography. Each purified protein was analyzed for (i) amino acid content, (ii) N-terminal amino acid sequence, (iii) C-terminal amino acid sequence, and (iv) phosphoamino acid content. The results of N-and C-terminal amino acid sequence analysis of each gag protein, taken together with the nucleotide sequence of the EIAV gag gene (R. M. Stephens, J. W. Casey, and N. R. Rice, Science 231:589-594, 1986), show that the order of the proteins in the precursor is p15-p26-*-p11-p9, where a pentapeptide also found in the virus is represented by the asterisk. The data are in complete agreement with the predicted structure of the gag polyprotein and show the peptide bonds cleaved during proteolytic processing. The N terminus of p15 is blocked to Edman degradation. The p11 protein is identical to the nucleic acid-binding protein of EIAV previously isolated (C. W. Long, L. E. Henderson, and S. Oroszlan, Virology 104: [491][492][493][494][495][496] 1980). High-titer rabbit antiserum was prepared against each purified protein. These antisera were used to detect the putative gag precursor (Pr55gag) and intermediate cleavage products designated Pr49 (plS-p26-*-pll), Pr4O (plS-p26), and Pr35 (p26-*-pll) in the virus and in virus-infected cells. High-titer antisera to EIAV p15 and p26 showed cross-reactivity with the homologous protein of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus.
The viral core proteins (pl5, p26, pll, and p9) of equine infectious anemia virus (EIAV) (Wyoming strain) were purifed by reverse-phase high-pressure liquid chromatography. Each purified protein was analyzed for (i) amino acid content, (ii) N-terminal amino acid sequence, (iii) C-terminal amino acid sequence, and (iv) phosphoamino acid content. The results of N-and C-terminal amino acid sequence analysis of each gag protein, taken together with the nucleotide sequence of the EIAV gag gene (R. M. Stephens, J. W. Casey, and N. R.
Rice, Science 231:589-594, 1986), show that the order of the proteins in the precursor is p15-p26-*-p11-p9, where a pentapeptide also found in the virus is represented by the asterisk. The data are in complete agreement with the predicted structure of the gag polyprotein and show the peptide bonds cleaved during proteolytic processing. The N terminus of p15 is blocked to Edman degradation. The p11 protein is identical to the nucleic acid-binding protein of EIAV previously isolated (C. W. Long, L. E. Henderson, and S. Oroszlan, Virology 104: [491] [492] [493] [494] [495] [496] 1980 ). High-titer rabbit antiserum was prepared against each purified protein. These antisera were used to detect the putative gag precursor (Pr55gag) and intermediate cleavage products designated Pr49 (plS-p26-*-pll), Pr4O (plS-p26), and Pr35 (p26-*-pll) in the virus and in virus-infected cells. High-titer antisera to EIAV p15 and p26 showed cross-reactivity with the homologous protein of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus.
Equine infectious anemia is a disease caused by chronic infection by a virus designated equine infectious anemia virus (EIAV) (24, 27, 28, 35) . EIAV is a retrovirus (5) with a high-molecular-weight (sedimentation coefficient, 60S to 70S) genomic RNA (7, 12, 36) , a viral reverse transcriptase with a preference for magnesium ions (1) , and morphology similar to C-type retroviruses (12, 51) . The virus has been subclassified as a lentivirus (12) . Other members of the lentivirus subfamily of retroviruses are human immunosuppressive viruses (HIVs) including human T-cpll lymphotropic virus type III (HTLV-III) (11) and type IV (26) , lymphadenopathy-associated virus (2) , and AIDS-associated retrovirus (31) ; simian immunosuppressive viruses including various simian T-lymphotropic viruses (10, 25, 26, 30) and Macaca nemestrina immunodeficiency virus (3); visna virus (48, 49) ; and caprine arthritis-encephalitis virus (37) . Recently, the nucleotide sequence of a fragment of EIAV proviral DNA including all of the gag gene and part of the pol gene has been determined (50) . The gag gene was identified as a long open reading frame that could code for a polypeptide of 486 residues designated Pr55gag. The predicted amino acid sequence of EIAV Pr55gag shared some homology with the sequences of the predicted gag polypeptides of HIVs and visna virus.
EIAV has been shown to contain at least four major internal polypeptides (6, 23, 40) that are believed to be proteolytic cleavage products of Pr55rag. The major internal proteins of EIAV have been designated p26, p15, pll, and p9 and have been isolated from disrupted virus by gel filtration chromatography in high concentrations of guanidine hydrochloride (34) . The amino acid compositions and pIs of the isolated proteins were reported, but no amino acid sequence data were reported for the purified EIAV proteins.
In this report we describe the isolation of the major internal proteins of EIAV (p26, p15, pll, and p9) by reversephase high-pressure liquid chromatography (RP-HPLC). We report the amino acid composition and results of N-and C-terminal amino acid sequence analysis and phosphoamino acid analysis for each purified protein. Gel electrophoresis. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (47) was performed on 10 to 20% gradient gels by the method of Laemmli (29) . Proteins were visualized by staining with Coomassie brilliant blue R-250 (Bio-Rad Laboratories, Richmond, Calif.).
Amino acid analysis. Samples for amino acid analysis were hydrolyzed for 24 h in vacuo with 6 N HCl containing 0.1% liquid phenol and then dried by vacuum desiccation. Analysis was performed with a Durrum D500 amino acid analyzer using ninhydrin detection of eluted amino acids. Cysteine was determined as cysteic acid after performic acid oxidation (22) . Tryptophan was determined spectrophotometrically from the A294.
O-Phosphoamino acid analysis. Samples were hydrolyzed in vacuo in 4 N HCI at 110°C for 1.5 h. After the HCl was removed by evaporation under reduced pressure, the samples were dissolved in 0.006 N HCI and injected onto an anion-exchange column (Synchropak AX300; SynChrom, Inc., Linden, Ind.). The phosphoamino acids were separated at 50°C by isocratic elution at a flow rate of 1.3 ml/min with 15 mM KH2PO4 adjusted to pH 3.0 with concentrated H3PO4 and made 12.5% (vol/vol) in methanol (52) . Eluted phosphoamino acids were detected by fluorescence after reaction with orthophthalaldehyde reagent (41) .
Liquid-phase sequencing. Semiautomated microsequencing was performed with an updated 890B Beckman sequencer, as previously described (8, 16) . Phenylthiohydantoin (PTH) derivatives of amino acids were quantitatively identified as previously described (15) .
Separation of viral proteins by RP-HPLC. Concentrated suspensions of purified virus (1 mglml) in 10 mM Tris hydrochloride (pH 7.2)-100 mM NaCI-1 mM EDTA were adjusted to pH 2.0 by the addition of TFA and added to 5 volumes of saturated (at 23°C) guanidine hydrochloride. The resulting slightly turbid solution of disrupted virus was injected into a high-pressure liquid chromatograph (Waters Associates, Inc., Milford, Mass.) and separated by RP-HPLC on an Ultrapore RPSC (C3) (Beckman) or ,uBondapak C18 column (Waters), as previously described for the separation of structural proteins from other retroviruses (9, 18, 20, 21, 39) . Eluted proteins were detected by UV absorption at 206 nm (19) with a model 450 (Waters) variablewavelength detector and collected manually to optimize separations and recoveries. Solvents were removed by lyophilization. The flow rate, elution solvent, and gradient conditions are given in the figure legends. After each separation of viral proteins, the RP-HPLC column was washed at 50°C with 120 ml of 1-propanol-water-TFA (90:10:0.1) at a flow rate of 0.2 ml/min. Columns were stored in 1-propanol or acetonitrile containing 0.1% TFA. When necessary, proteins were rechromatographed on a Bakerbond wide-pore diphenyl column (J. T. Baker Research Products, Phillipsburg, N.J.). Columns were frequently monitored for their ability to separate a standard mixture of proteins and peptides (50 ,ug each of bovine serum albumin, ovalbumin, lysozyme, RNase, Met-enkephalin, and Leu-enkephalin), as previously described (14) . When necessary, columns were cleaned and repacked as previously described (19) .
Immunization. EIAV p26 and p15 proteins purified by RP-HPLC were further purified by preparative SDS-PAGE. The protein bands were located in the gel by visualization in the presence of 0.1 M KCI (13) booster injections of 50 ,ug of protein each, given at 2-week intervals. The immunized rabbits were bled out 1 week after the final booster injection, and the sera were tested for monospecific antibodies to purified EIAV proteins immobilized on diazopaper. Adsorbed antibodies were detected by complex formation with 1251I-labeled protein A followed by autoradiography.
Immune-transfer analysis. Proteins separated by SDS-PAGE were transferred and fixed to diazo paper by transverse electrophoresis (44) . The excess diazo groups were reacted with 10% powdered milk protein -0.1 M phosphate (pH 9), and antigens were detected by reaction with monospecific antisera against EIAV proteins. Antigen-antibody complexes were reacted with 251I-labeled protein A and detected by autoradiography.
RESULTS
Proteins associated with purified EIAV were separated by RP-HPLC. A typical RP-HPLC chromatogram obtained from the separation of EIAV proteins is shown in Fig. 1 . The proteins collected in effluent fractions a, b, c, and d ( Fig. 1) were pooled with identical fractions from other separations of EIAV proteins performed in the same manner. Each pool of partly purified protein was lyophilized and rechromatographed by RP-HPLC on a Bakerbond diphenyl column (results not shown) by essentially the same procedure as that described for the chromatography shown in Fig. 1 . The repurified proteins were then analyzed and identified by SDS-PAGE ( Fig. 2A) . The major viral protein identified with each UV peak is indicated in Fig. 1 (pll, p9, p26, and p15). The pll, p9, and p15 proteins ( Fig. 2A) were taken for chemical analysis without further purification. The p26 protein ( Fig. 2A ) was rechromatographed as in the experiment shown in Fig. 1 except that a more shallow gradient of acetonitrile was used to elute the protein (results not shown). The repurified p26 protein was reanalyzed by SDS-PAGE ( Fig. 2B ) and taken for chemical analysis.
The amino acid compositions of the EIAV p9, pll, p26, and p15 proteins purified as described above were determined (Table 1) of p26 and p15 are in good agreement with the results of Montelaro et al (34) . Our results for the amino acid composition of EIAV pll are in good agreement with the amino acid composition of the DNA binding-protein purified from EIAV by Long et al (32) .
The p26 and p15 proteins of EIAV had mobilities in SDS-PAGE that were consistent with their molecular weights based on amino acid analysis of the purified proteins ( Table 1) . The p9 and pll proteins appeared to comigrate in the SDS-PAGE shown in Fig. 2 ; however, in other experi- pl1 G1 n-Thr-Gly-Leu-A1 a-Gly-Pro-Phe-Lys-Gly-Gly-Al a-Leu-Lys-Gly-Gly-Pro-Leu-Lys-Al a-25 Ala-Gln-X -X -Tyr- Asn-5  10  15  20  p9 Pro-1le-Gl n-Gl n-Lys-Ser-Gl n-His-Asn-Lys-Ser-Val -Val -G1 n-Gl u-Thr-Pro-X -Thr-XAsn-Leu- Tyr-5  10  15  20 p27 Pro-I le-Met-I1 e-Asp-Gly-Ala-Gly-Asn-Arg-Asn-Phe-Arg-Pro-Leu-Thr-Pro-Arg-Gly-Tyr- ments we observed pll migrating slightly more slowly than p9. The results of amino acid analysis (Table 1) suggest that pll is composed of about 76 amino acid residues, with a calculated molecular weight of about 8,000, and that p9 is composed of about 51 residues, with a calculated molecular weight of about 6,000. The discrepancy between the molecular weights of pll and p9 determined by mobility in SDS-PAGE and by amino acid analysis was probably due to the inaccuracy of the SDS-PAGE methods for the estimation of molecular weights of small proteins.
Each of the purified proteins of EIAV (p26, p15, pll, and p9) was also analyzed for phosphoamino acid content by a method using mild acid hydrolysis followed by separation and quantitation of phosphothreonine, phosphoserine, and phosphotyrosine by anion-exchange chromatography (52) . Analysis of p26, pll, p15, and p9 gave no detectable peaks eluting in the region of the phosphoamino acids. (34) .
The purified proteins of EIAV (p26, p15, pll, and p9) were each taken for automated N-terminal Edman degradation, and the PTH-amino acid derivative obtained from each Edman cycle was identified by HPLC (15) . The N-terminal amino acid sequences of p26, pll, and p9 deduced by Edman degradation are presented in Fig. 3 . No PTH-amino acid derivatives were produced by Edman degradation of p15, indicating that this protein is blocked to Edman degradation and may have a derivatized N-terminal amino group.
Each of the purified EIAV proteins was digested with a carboxypeptidase for various times, and the liberated free amino acids were analyzed to determine residues at the C terminus of the protein. The results showing the rate of release of amino acid residues from EIAV pll, p9, p26, and p15 by enzymatic digestion with carboxypeptidase A are given in Table 2 . The C-terminal amino acid sequence was suggested by the rate of release of residues and is shown in Fig. 4 for each EIAV protein.
The N-terminal amino acid sequences of the EIAV proteins given in Fig. 3 and the C-terminal amino acid sequences given in Fig. 4 , as well as the amino acid compositions (Table  1) , were compared with the deduced amino acid sequence (50) of EIAV Pr55gag predicted by translation of the proviral DNA sequence (Fig. 5) . The C-terminal residues of p15 and the N-terminal residues of p26 are identical to a contiguous sequence of residues from positions 124 to 152 in the predicted structure of P655gag. Proteolysis between p15 and p26 occurred at a single peptide bond between residues 124 and 125. In a similar manner, it was shown that the Cterminal residues of pll and the N-terminal sequence of p9 are identical to a contiguous amino acid sequence in Pr55gag (residues 432 to 458) and proteolysis between pll and p9 occurred at a single peptide bond between residues 435 and 436. The C-terminal amino acid residues determined for the p9 protein align with the predicted C-terminal residues of Pr55gag except that our method of analysis could not determine tryptophan (the predicted penultimate tryptophan residue). The C-terminal residues of p26 and the N-terminal residues of pll do not align with a contiguous predicted amino acid sequence in P655gag. The C-terminal residue of p26 aligns with residue 354 of P655gag, and the N-terminal residue of pll aligns with residue 360. Thus, there are five residues predicted between the C terminus and p26 and the N terminus of pll. A peptide with an amino acid composition identical to the predicted composition of the five-residue segment between p26 and pll was searched for and was found in early-eluting fractions of the chromatogram shown in Fig. 1 .
The determined amino acid compositions of p15, pll, and p9 are in excellent agreement with the predicted compositions of these proteins based on the determined proteolytic cleavage sites and predicted amino acid sequence of Pr55gag (values in parentheses in Table 1 ). The predicted amino acid composition of p15 includes two methionine residues (residues 1 Thus, it appears that p15, p26, pll, p9, and the pentapeptide could account for all residues of Pr55rar predicted by the nucleotide sequence of the EIAV gag gene, except the initiator methionine. The results show that the structure of Pr55gag is p15-p26-*-pll-p9, where the pentapeptide is represented by an asterisk.
Rabbits were immunized with the purified EIAV proteins to prepare monospecific antisera directed against each of the EIAV proteins (anti-p26, anti-p15, anti-pll, and anti-p9). The monospecific antisera were used to examine the virus and virus-infected cells for related proteins.
Purified whole EIAV was disrupted, separated by SDS-PAGE, and transferred to diazo paper (44) , and viral antigens on individual strips of paper were detected by reaction with each of the monospecific antisera (anti-p15, anti-p26, anti-p9, or anti-pll). Antigen-antibody complexes were visualized by radioautography after reaction with 125I-labeled protein A. The results of a 4-h exposure of the realigned strips are shown in Fig. 6A , and the results of an 18-h exposure of the upper parts of the same strips are shown in Fig. 6B. In Fig. 6A it can be seen that each of the monospecific antisera reacted with a unique set of viral proteins. The anti-p15 serum (lane 1) reacted with p15 and a lowermolecular-weight band (approximately 4,000) and also detected bands labeled Pr4O, Pr49, and Pr55. The anti-p26 serum (lane 2) detected bands labeled Pr4O, Pr49, and Pr55 but did not detect bands at 15,000 or 4,000. In addition, the anti-p26 serum detected bands labeled Pr35 and p26 and lower-molecular-weight bands of about 23,000, 22,000, and 18,000. The anti-p9 serum (lane 3) detected bands labeled Pr55 and p9 but did not detect any other bands. The anti-pll serum (lane 4) detected a band labeled pll but did not detect any other viral protein bands. However, in other experiments (Fig. 6C ) using lower dilutions of anti-pll, it was possible to detect a weak reaction with Pr49 and Pr35. The monospecific nature of the anti-p15, anti-p26, anti-p9, and anti-pll sera is indicated by the data shown in Fig. 6 and was confirmed by testing their reactivity against purified viral proteins (data not shown). The peptide bonds in PM55Y"' cleaved by proteolysis were determined by aligning the N-and C-terminal amino acid sequences of p26, pll, and p9 and the C-terminal residue of p15 with the deduced amino acid sequence of EIAV Pr55gag (50) . The peptide bonds cleaved are indicated by triple dots and an arrow. The numbers above residues indicate the positions of the residues in the deduced amino acid sequence of Pr559aR. The cleavage products p15, p26, pentapeptide, pll, and p9 are indicated by solid lines and were all isolated from mature viruses.
The proteins precipitated from EIAV-infected EFK cells with anti-p26 serum and detected by immune transfer with anti-p26 serum are shown in Fig. 7 , lane 2. Proteins present in whole EIAV were also included in the same gel as positive controls (Fig. 7, lane 1) . The proteins visualized in Fig. 7 , lane 1 are equivalent to those visualized in Fig. 6 , lane 2. Very little p26 was detected in the infected-cell cultures (Fig.  7, lane 2) , suggesting that mature viral particles were effectively separated from the cells before the immune precipitation. Precipitations performed with anti-p15 serum and detected with anti-p26 serum gave results identical to those shown in Fig. 7 , except that p26 was not detected. Precipitations and detections with preimmune rabbit sera gave no detectable bands at this level of exposure. The data presented in Fig. 7 show that proteins equivalent to PrS5, Pr49, and Pr4O were present in the EIAV-infected cells. However, the infected cells appear to have contained a higher proportion of Pr4O (relative to Pr55 and Pr49) than was found in the virus.
PrSS shares antigenic determinants with p15, p26, and p9 and has an apparent molecular weight of 55,000, in good agreement with the sum of the molecular weights of p15 (ca. 14,000), p26 plus the pentapeptide (ca. 27,500), p9 (ca. 6,000), and pll (ca. 8,000), which is equal to 55,500. Pr49 contains antigenic determinants common to p15, p26, and A PrSSp26 p15-^] pIl,p9 B pll but not to p9 and has an apparent molecular weight of 49,000, in agreement with the sum of the molecular weights for pi5, p26, and pll (ca. 49,500). Pr4O shares antigenic determinants with p15 and p26, and its apparent molecular weight of 39,000 is within experimental error for the sum of the molecular weights of p15 and p26 (ca. 41,500). Pr35 shares antigenic determinants with p26 and pll but not with p15 or p9, and its apparent molecular weight is 35,000, in good agreement with the sum of the molecular weights of p26 (plus the pentapeptide) and pll (ca. 35,500).
We interpret these data by assuming that PrSS is the gag precursor polyprotein of EIAV and that Pr49, Pr4O, Pr35, p15, p26, p9, and pll are all derived by proteolytic cleavage of PrSS. The data are consistent with this assumption and the proven gene order for EIAV Pr55ga_ (plS-p26-*-pll-p9), as shown in Fig. 8 . The fact that anti-pll serum did not react with PrS5 remains unexplained but suggests that major antigenic determinants for pll may involve the terminal amino or carboxyl group or both.
In other experiments, EFK cells infected with EIAV were incubated with [3H]myristic acid and examined for the presence of metabolically labeled PrS5, as previously described for the detection of other retroviral gag precursor polyproteins (45, 46) . These experiments failed to show detectable amounts of myristylated Pr55. Antigens present in EIAV detected by immune transfer with monospecific antisera to p15, p26, p9, and pll. EIAV proteins were separated by SDS-PAGE in a slab gel apparatus with a 12-cm-wide application well. After separation, the proteins were transferred and fixed to diazo paper. Vertical strips cut from the diazo paper were stained individually with 1:1,000 dilutions of monospecific antisera to p15 (lanes 1), p26 (lanes 2), p9 (lanes 3), and pll (lanes 4) and reacted with 125I-labeled protein A. The strips were then realigned, and the antigen-antibody complexes were detected by radioautography. (A) Results of a 4-h exposure of the realigned strips to film; (B) upper parts of the realigned strips exposed to the film for 18 h; (C) results obtained with anti-pll serum at a 1:100 dilution (lane a) aligned with a strip reacted with anti-p26 serum (lane b). In other experiments performed as described above, radiolabeled molecular weight marker proteins were run in an adjacent lane to calibrte the gel for estimation of the apparent molecular weights of the viral antigens (results not shown). The monospecific antisera (anti-p15, anti-p26, anti-pll, and anti-p9) were all tested in immune transfer against separated proteins present in various purified retroviruses including HTLV-I, HTLV-III, avian reticuloendotheliosis virus, Rous sarcoma virus, Moloney murine leukemia virus, mouse mammary tumor virus, Mason-Pfizer monkey virus, and retrovirus-D/Washington. Positive reactions were detected between anti-EIAV p26 serum and HTLV-III p24 (Fig. 9, lane 1) and between anti-EIAV p15 serum and HTLV-III p17 (Fig. 9, lane 4) of immunoblot bands for EIAV p24 and HTLV-III p26 (Fig.  9 , cf. lanes 2 and 1) and for EIAV p15 and HTLV-III p17 (Fig. 9, cf. lanes 3 and 4) probably reflect weak crossreactivity between the specific EIAV antiserum and the homologous HTLV-III protein. In other experiments (data not shown), purified HTLV-III p24 and p17 were used to confirm the identities of the cross-reactive proteins. DISCUSSION Previous studies have shown that EIAV is composed of at least four proteins (6, 23, 34, 40) believed to be associated with the internal structure of the virus. In this study we purified four major proteins (pll, p9, p26, and p15) and a pentapeptide from EIAV by RP-HPLC by using essentially the same techniques and procedures previously used to purify major internal structural proteins from B-type (21), C-type (18) , and D-type (20) retroviruses and other retroviruses such as HTLV-I(9, 39).
Each purified protein was analyzed for its N-and Cterminal amino acid sequences and amino acid and phosphoamino acid content. The proteins were located in the deduced structure of the EIAV Pr55gag polyprotein by aligning the deduced amino acid sequence with the experimentally determined amino acid sequences. This gave the order of the proteins in the structure of Pr559'9 as p15-p26-*-pll-p9, where a pentapeptide between p26 and pll is represented by the asterisk, and also showed that all portions of Pr55gag except the initiator methionine were accounted for among the purified proteins and peptides.
The data also reveal the peptide bonds cleaved during proteolytic processing of Pr55ga': Tyr-Pro between p15 and p26; Leu-Leu between p26 and the pentapeptide; Leu-Gln between the pentapeptide and pll; and Phe-Pro between pll and p9. The peptide bonds cleaved during proteolytic processing of EIAV Pr55gag have a striking resemblance to the bonds cleaved during proteolytic processing of murine Ctype retroviruses (Tyr-Pro, Phe-Pro, Leu-Ala, Leu-Thr, and Leu-Val) (18, 38) .
Monospecific antiserum was prepared against each of the purified proteins (p15, p26, pll, and p9) and used to detect polyproteins in the mature virus and in virus-infected cells. The results showed that the mature virus contained a protein, desighated here as Pr55, with antigenic determinants in common with p15, p26, and p9. In addition, proteins with molecular Weights and antigenicity consistent with the following putative partial proteolytic cleavage fragtnents of Pr55 were also detected: Pr49 (p15-p26-*-pll), Pr4O (p15-p26 or pl5-p26-* or both), and Pr35 (p26-*-pll). Thus, the data taken together strongly suggest that Pr55 is the gag precursor predicted by translation of the nucleotide sequence of the gag gene and that the major internal proteins of the virus are produced by proteolysis of a common precursor, as is the case for all other retroviruses. The polyproteins Pr55, Pr49, Pr4O, and Pr35 were also detected in virus-infected cells. Since the cell preparation could have contained adherent immature forms of the virus, it is not possible to conclude that cleavage of the precursor initiates before virus assembly. However, based on the apparent preponderance of Pr40gag found in the cell preparation, it appears that proteolytic cleavage between p15 and p26 may be a slow step in proteolytic processing. A kinetic analysis would be needed to firmly establish the relative rates of cleavage of various peptide bonds and to confirm precursor-product relationships implied here.
The Mature virus also contained traces of polypeptides with apparent molecular weights of 23,000, 22,000, and 18,000 detected with anti-p26 serum and a 4,000-molecularweight polypeptide detected with anti-p15 serum. These polypeptides were not further characterized but probably represent minor proteolytic cleavage fragments of p26 and p15.
A relationship between EIAV and HIV was first suggested on the basis of immunological cross-reactivity observed with anti-EIAV sera and HIV p24 (4, 33) . The distant but distinct relationship was shown in detail by a comparison of the nucleotide sequences of HIV (42) and EIAV (50) . In this study, we confirmed the original observations of antigenic cross-reactivity with more defined antisera by showing that anti-EIAV p26 serum reacted with HTLV-III p24 and in addition showed that anti-EIAV p15 serum reacted with HTLV-III p17.
Many retroviruses including mammalian C-type, D-type, B-type, HTLV-I, bovine leukemia virus, and HTLV-III have gag polyproteins that are modified by a two-step mechanism involving proteolytic removal of the initiator methionine-followed by covalent attachment of a myristyl moiety [CH3(CH2)12CO-] to the newly formed N-terminal glycine residue (17, 45, 46) . It has recently been shown that myristylation requires an N-terminal glycine residue and is essential for assembly or budding or both of the murine C-type virus (43) . The predicted N-terminal amino acid sequence of PrS55ga is Met-Gly-Asp-Pro-Leu-Thr (50) . EIAV p15 appears to be lacking the initiator methionine ( 
